Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased 18 F‐FDOPA uptake

Archive ouverte

Somme, François | Montaz‐rosset, Marie‐soline | Averous, Gerlinde | Deur, Jeanne | Goichot, Bernard | Bachellier, Philippe | Addeo, Pietro | Imperiale, Alessio

Edité par CCSD ; Wiley -

International audience. ObjectiveTo assess the specificity of increased 18F‐dihydroxyphenylalanine (18F‐FDOPA) uptake in patients who underwent PET/CT for suspicion of isolated pancreatic neuroendocrine tumour (pNET). False‐positive results mimicking a pNET have been investigated.Material and methodsCarbidopa‐assisted 18F‐FDOPA PET/CT scans performed in patients with suspicion of localized pNET were retrieved. Only patients with a definitive diagnosis were retrospectively included. When available, the histopathological result after pancreatic surgery was the gold standard. In other cases, the diagnosis was based on endoscopic ultrasonography (EUS)/cytology and/or on concordant imaging results of at least two of the following: contrast‐enhanced computed tomography (CE‐CT), magnetic resonance imaging (MRI) and somatostatin receptor scintigraphy (SRS).ResultsForty‐four among 731 patients were selected. Among these, 36 patients (82%) were surgically treated, revealing pNET (n = 28), solid pseudopapillary tumour (SPT) (n = 4), adenocarcinoma (n = 2), serous cystadenomas (n = 1) and solitary fibrous tumour (n = 1) cases. An additional three cases of pNET were diagnosed by EUS/cytology. In the remaining five patients, a consensus was reached on follow‐up imaging results: pNET (n = 1), serous cystadenoma (n = 2) and undetermined/no pNET (n = 2). Both specificity and negative predictive value of 18F‐FDOPA PET/CT for localized pNET were 67%. Surprisingly, all four false‐positive results were SPTs showing intense 18F‐FDOPA uptake and negative SRS. There was no significant difference in 18F‐FDOPA uptake intensity between PET‐positive pNETs and SPTs.Conclusion18F‐FDOPA PET/CT is not specific for pNET in patients with localized pancreatic lesions. SPT could mimic pNET and should be part of differential diagnosis in such a clinical situation. If these results are confirmed in a broader population, the imaging pattern 18F‐FDOPA PET‐positive/SRS‐negative lesions might be considered as the imaging phenotype of SPT.

Consulter en ligne

Suggestions

Du même auteur

Limited role of carbidopa-assisted (18)F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms

Archive ouverte | Imperiale, Alessio | CCSD

OBJECTIVE: To evaluate (18)F-fluorodihydroxyphenylalanine ((18)F-FDOPA) positron emission tomography/computed tomography (PET/CT) after carbidopa premedication to localize sporadic, well-differentiated, nonfunctioning gastroduoden...

18F-FDOPA PET/CT of Nonfunctioning Paraganglioma of the Gastroepiploic Pedicle

Archive ouverte | Leroy Freschini, Benjamin | CCSD

We report the case of a 54-year-old woman with a nonfunctioning paraganglioma arising from the gastroepiploic pedicle demonstrated by F-FDOPA PET/CT. Because gastroepiploic arcade can be assimilated to the gastric mesentery, this ...

Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases

Archive ouverte | Addeo, Pietro | CCSD

International audience. BackgroundThis study evaluated the short- and long-term outcomes of synchronous resection of liver metastases (LM) from small bowel neuroendocrine tumors (SB-NET).MethodsA retrospective revie...

Chargement des enrichissements...